{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:24:26Z","timestamp":1786933466078,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16338-y","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:25:52Z","timestamp":1781144752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HEPACAM2 expression for prognostic stratification in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Eric Yi-Liang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Wei","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Din-Li","family":"Tsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chieh","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"3","key":"16338_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"16338_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"16338_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset J-F, Etienne P-L, Rio E, Fran\u00e7ois \u00c9, Mesgouez-Nebout N, Vendrely V, Artignan X, Bouch\u00e9 O, Gargot D, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702\u201315.","journal-title":"Lancet Oncol"},{"issue":"10","key":"16338_CR4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","volume":"35","author":"T Conroy","year":"2024","unstructured":"Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L, Vendrely V, Artignan X, Bouch\u00e9 O, Gargot D, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. 2024;35(10):873\u201381.","journal-title":"Ann Oncol"},{"issue":"1","key":"16338_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, Van Etten B, Marijnen CAM, Putter H, Kranenbarg EM-K, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29\u201342.","journal-title":"Lancet Oncol"},{"issue":"34","key":"16338_CR6","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","volume":"23","author":"C R\u00f6del","year":"2005","unstructured":"R\u00f6del C, Martus P, Papadoupolos T, F\u00fczesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, et al. Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer. J Clin Oncol. 2005;23(34):8688\u201396.","journal-title":"J Clin Oncol"},{"issue":"15","key":"16338_CR7","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1200\/JCO.2013.54.3769","volume":"32","author":"E Fokas","year":"2014","unstructured":"Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, Becker H, Ghadimi M, Mrak K, Merkel S, et al. Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO\/ARO\/AIO-94 Trial. J Clin Oncol. 2014;32(15):1554\u201362.","journal-title":"J Clin Oncol"},{"issue":"5","key":"16338_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.molcel.2012.06.033","volume":"47","author":"Y Ozaki","year":"2012","unstructured":"Ozaki Y, Matsui H, Asou H, Nagamachi A, Aki D, Honda H, Yasunaga S, Takihara Y, Yamamoto T, Izumi S, et al. Poly-ADP ribosylation of Miki by tankyrase-1 promotes centrosome maturation. Mol Cell. 2012;47(5):694\u2013706.","journal-title":"Mol Cell"},{"issue":"1","key":"16338_CR9","doi-asserted-by":"publisher","first-page":"e35557","DOI":"10.1002\/cncr.35557","volume":"131","author":"KS McColl","year":"2025","unstructured":"McColl KS, Ajay A, Wang H, Wildey GM, Yoon S, Grubb B, Kopp SR, Joseph PL, Saviana M, Romano G, et al. Identification of HEPACAM2 as a novel and specific marker of small cell carcinoma. Cancer. 2025;131(1):e35557.","journal-title":"Cancer"},{"issue":"23","key":"16338_CR10","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.7150\/jca.32267","volume":"10","author":"GL Zhang","year":"2019","unstructured":"Zhang GL, Pan LL, Huang T, Wang JH. The transcriptome difference between colorectal tumor and normal tissues revealed by single-cell sequencing. J Cancer. 2019;10(23):5883\u201390.","journal-title":"J Cancer"},{"issue":"6","key":"16338_CR11","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/cam4.1484","volume":"7","author":"Z Wu","year":"2018","unstructured":"Wu Z, Liu Z, Ge W, Shou J, You L, Pan H, Han W. Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence. Cancer Med. 2018;7(6):2555\u201366.","journal-title":"Cancer Med"},{"issue":"4","key":"16338_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/0115665232325395241018103006","volume":"25","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang L, Li D, Gou M. Comprehensive Analysis and Experimental Validation of HEPACAM2 as a Potential Prognosis Biomarker and Immunotherapy Target in Colorectal Cancer. Curr Gene Ther. 2025;25(4):518\u201331.","journal-title":"Curr Gene Ther"},{"issue":"7","key":"16338_CR13","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1158\/0008-5472.CAN-05-3834","volume":"66","author":"T Watanabe","year":"2006","unstructured":"Watanabe T, Komuro Y, Kiyomatsu T, Kanazawa T, Kazama Y, Tanaka J, Tanaka T, Yamamoto Y, Shirane M, Muto T, et al. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res. 2006;66(7):3370\u20134.","journal-title":"Cancer Res"},{"issue":"1","key":"16338_CR14","first-page":"492","volume":"17","author":"Q Peng","year":"2019","unstructured":"Peng Q, Lin K, Shen Y, Zhou P, Fan S, Shen Y, Zhu Y. Identification of potential genes and pathways for response prediction of neoadjuvant chemoradiotherapy in patients with rectal cancer by systemic biological analysis. Oncol Lett. 2019;17(1):492\u2013501.","journal-title":"Oncol Lett"},{"key":"16338_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/OTT.S488608","volume":"18","author":"CL Chou","year":"2025","unstructured":"Chou CL, Lin CW, Li WS, Chen TJ, Lee SW, Tian YF, Kuo YH, Tsai HH, Wu LC, Yeh CF, et al. High Intelectin-1 Expression Associated with Aggressive Tumor Behavior and Worse Survival in Rectal Cancer. Onco Targets Ther. 2025;18:15\u201326.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"16338_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12964-017-0192-z","volume":"15","author":"X Li","year":"2017","unstructured":"Li X, Hu W, Zhou J, Huang Y, Peng J, Yuan Y, Yu J, Zheng S. CLCA1 suppresses colorectal cancer aggressiveness via inhibition of the Wnt\/beta-catenin signaling pathway. Cell Communication Signal. 2017;15(1):38.","journal-title":"Cell Communication Signal"},{"issue":"12","key":"16338_CR17","first-page":"1183","volume":"22","author":"XJ Wang","year":"2019","unstructured":"Wang XJ, Yu Q, Chi P, Lin HM, Lu XR, Huang Y, Xu ZB, Huang SH, Sun YW, Ye DX. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis]. Zhonghua Wei Chang Wai Ke Za Zhi. 2019;22(12):1183\u20137.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"16338_CR18","doi-asserted-by":"publisher","unstructured":"Lee J, Kwon J, Kim D, Park M, Kim K, Bae I, Kim H, Kong J, Kim Y, Shin U, et al. Gene Expression Profiles Associated with Radio-Responsiveness in Locally Advanced Rectal Cancer. Biology (Basel). 2021;10(6):500. https:\/\/doi.org\/10.3390\/biology10060500.","DOI":"10.3390\/biology10060500"},{"issue":"1","key":"16338_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12964-024-01879-1","volume":"22","author":"M Anbazhagan","year":"2024","unstructured":"Anbazhagan M, Sharma G, Murthy S, Maddipatla SC, Kolachala VL, Dodd A, Randunne A, Cutler DJ, Kugathasan S, Matthews JD. PTGER4 signaling regulates class IIa HDAC function and SPINK4 mRNA levels in rectal epithelial cells. Cell Commun Signal. 2024;22(1):493.","journal-title":"Cell Commun Signal"},{"key":"16338_CR20","doi-asserted-by":"publisher","unstructured":"Zheng H-C, Xue H, Zhang C-Y. REG4 promotes the proliferation and anti-apoptosis of cancer. Front Cell Dev Biol. 2022;10:1012193. https:\/\/doi.org\/10.3389\/fcell.2022.1012193.","DOI":"10.3389\/fcell.2022.1012193"},{"key":"16338_CR21","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.2147\/OTT.S243750","volume":"13","author":"CL Chou","year":"2020","unstructured":"Chou CL, Chen TJ, Lin CY, Lee SW, Wang SC, Chu SS, Yang CC. PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis. Onco Targets Ther. 2020;13:3141\u201350.","journal-title":"Onco Targets Ther"},{"issue":"7503","key":"16338_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nature13277","volume":"510","author":"SA Godinho","year":"2014","unstructured":"Godinho SA, Picone R, Burute M, Dagher R, Su Y, Leung CT, Polyak K, Brugge JS, Th\u00e9ry M, Pellman D. Oncogene-like induction of cellular invasion from centrosome amplification. Nature. 2014;510(7503):167\u201371.","journal-title":"Nature"},{"issue":"1","key":"16338_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-020-20208-x","volume":"12","author":"G Fan","year":"2021","unstructured":"Fan G, Sun L, Meng L, Hu C, Wang X, Shi Z, Hu C, Han Y, Yang Q, Cao L, et al. The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation. Nat Commun. 2021;12(1):20.","journal-title":"Nat Commun"},{"issue":"11","key":"16338_CR24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1158\/1541-7786.MCR-17-0205","volume":"15","author":"G Emons","year":"2017","unstructured":"Emons G, Spitzner M, Reineke S, M\u00f6ller J, Auslander N, Kramer F, Hu Y, Beissbarth T, Wolff HA, Rave-Fr\u00e4nk M, et al. Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt\/\u03b2-catenin Signaling. Mol Cancer Res. 2017;15(11):1481\u201390.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"16338_CR25","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/carcin\/bgr222","volume":"32","author":"E Kendziorra","year":"2011","unstructured":"Kendziorra E, Ahlborn K, Spitzner M, Rave-Fr\u00e4nk M, Emons G, Gaedcke J, Kramer F, Wolff HA, Becker H, Beissbarth T, et al. Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis. 2011;32(12):1824\u201331.","journal-title":"Carcinogenesis"},{"issue":"12","key":"16338_CR26","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1080\/0284186X.2016.1230274","volume":"55","author":"M Nikberg","year":"2016","unstructured":"Nikberg M, Chabok A, Letocha H, Kindler C, Glimelius B, Smedh K. Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncol. 2016;55(12):1418\u201324.","journal-title":"Acta Oncol"},{"issue":"6","key":"16338_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/jso.25367","volume":"119","author":"LGJ Leijssen","year":"2019","unstructured":"Leijssen LGJ, Dinaux AM, Amri R, Taylor MS, Deshpande V, Bordeianou LG, Kunitake H, Berger DL. Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes. J Surg Oncol. 2019;119(6):749\u201357.","journal-title":"J Surg Oncol"},{"key":"16338_CR28","doi-asserted-by":"publisher","unstructured":"De Mattia E, Polesel J, Mezzalira S, Palazzari E, Pollesel S, Toffoli G, Cecchin E. Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis. Cancers (Basel). 2023;15(5):1469. https:\/\/doi.org\/10.3390\/cancers15051469.","DOI":"10.3390\/cancers15051469"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16338-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16338-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16338-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:40:52Z","timestamp":1786930852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16338-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16338"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16338-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (2013 revision). Institutional review board approval was obtained from Chi Mei Medical Center (IRB: CMFHR10801-001), and all participants provided written informed consent for tissue analysis and use of clinical data.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"988"}}